21520
METHODS : We evaluated the incidence of CV events in patients treated with alogliptin , placebo or comparator antihyperglycaemic drugs in the clinical trial database for alogliptin using the composite major adverse cardiovascular event ( MACE ) endpoints of CV death , non - fatal myocardial infarction and non - fatal stroke .
 alogliptin, alogliptin
Please list all entity words in the text that fit the category. Output format is "word1, word2". 
Option: Chemical 
Text: {0} 
Answer:
 alogliptin, alogliptin